Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Covington Represents Cartesian Therapeutics in Securing up to $150M Financing from K2 Health Ventures

Press Release May 27, 2026

NEW YORK—Covington advised Cartesian Therapeutics, Inc., a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, in its entry into an agreement with K2 HealthVentures LLC, an alternative investment firm that provides flexible, long-term financing solutions in life sciences, to provide a credit facility of up to $150 million of term loans, of which an initial $50 million tranche was funded upon signing of the agreement.

The Covington team included Jennifer Uren, Matt Foster, and Amina Stone-Taylor (debt finance), Brian K. Rosenzweig, Sarah Griffiths, and Mark Edlund (securities/capital markets), and Kurt Baca and Lingyun Li (tax).

Share links:

Share links:

Related Professionals

Related Practices

Related Industries

Related Offices

Related News & Insights